SCHEMBL29980296

SCHEMBL29980296

CC(C)(C)OC(=O)N1CCN(CC2CCCCC2)C(=O)C1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 3/20 0.48
EPHX1 P07099 1/20 0.44
HPGD P15428 1/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
BACE1 P56817 3/20 0.41
CTSD P07339 1/20 0.41
FPR2 P25090 1/20 0.41
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE7A Q13946 1/20 0.40
TP53 P04637 1/20 0.39
KDM4E B2RXH2 1/20 0.38
THRB P10828 1/20 0.38
NR1H2 P55055 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31571027 0.99 P2RX7 (0.47) P2RX7EPHX1HPGDMAPTMEN1
SCHEMBL1584560 0.96 P2RX7 (0.47) P2RX7EPHX1HPGDMAPTMEN1
SCHEMBL1583284 0.93 P2RX7 (0.46) P2RX7HPGDMAPTMEN1ALDH1A1
Heptane SCHEMBL31571107 0.92 P2RX7 (0.42) P2RX7EPHX1HPGDMAPTMEN1
SCHEMBL25202856 0.88 DDB1 (0.41) P2RX7HPGDMAPTMEN1ALDH1A1
SCHEMBL15000449 0.88 USP2 (0.47) P2RX7MAPTALDH1A1FPR2DDB1
SCHEMBL6895303 0.84 MAPT (0.41) P2RX7MAPTMEN1ALDH1A1KMT2A
SCHEMBL6895307 0.84 MAPT (0.41) P2RX7MAPTMEN1ALDH1A1KMT2A
SCHEMBL28437919 0.82 NR1H2 (0.43) MAPTALDH1A1DDB1CRBNTP53
SCHEMBL15770892 0.81 FPR2 (0.47) EPHX1HPGDMAPTBACE1FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4284365-A1 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2023-12-06 EP disclosed
CN-117177744-A CDK2 inhibitors and methods of use thereof 塞迪拉治疗股份有限公司 2023-12-05 CN disclosed
WO-2022165513-A1 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2022-08-04 WO disclosed